The antifungal nail drugs market is projected to grow from USD 3.6 billion in 2026 to USD 7.7 billion by 2036, at a CAGR of 7.9%. Azoles will dominate with a 36.0% market share, while outpatient dermatology clinics will lead the treatment settings segment with a 42.0% share.